Immune Dysfunction-Associated Elevated RDW, APACHE-II, and SOFA Scores Were a Possible Cause of 28-Day Mortality in Sepsis Patients
DOI: https://doi.org/10.2147/idr.s442169
2024-03-27
Infection and Drug Resistance
Abstract:Jing Wang, 1, &ast Lisha He, 2, &ast Zhiyan Jin, 1, &ast Guoguang Lu, 1 Sufei Yu, 1 Lingling Hu, 1 Meidan Fang, 1 Xiaxia Jin 1 1 Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Taizhou, Zhejiang Province, People's Republic of China; 2 Department of Ultrasound, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Taizhou, Zhejiang Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Meidan Fang; Xiaxia Jin, Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, Taizhou, Zhejiang Province, People's Republic of China, Tel +86 13586102337; +86 15967063239, Email ; Objective: To explore the early predictors and their predicting value of 28-day mortality in sepsis patients and to investigate the possible causes of death. Methods: 127 sepsis patients were included, including 79 cases in the survival group and 48 cases in the death group. The results of all patients on admission were recorded. After screening the risk factors of 28-day mortality, the receiver operating characteristic curve (ROC) was used to determine their predictive value for the 28-day mortality rate on admission, and the Kaplan-Meier curve was drawn to compare the 28-day mortality rate between groups. Finally, patients with cytokine and lymphocyte subsets results were included for investigating the possible causes of death through correlation analysis. Results: APACHE II (acute physiology and chronic health evaluation II), SOFA (Sequential Organ Failure Assessment) and red blood cell distribution width (RDW) were the risk factors for 28-day mortality in sepsis patients (OR: 1.130 vs.1.160 vs.1.530, P < 0.05). The area under the curve (AUC), sensitivity and specificity of APACHE II, SOFA and RDW in predicting the mortality rate at 28 days after admission in sepsis patients were 0.763 vs 0.806 vs 0.723, 79.2% vs 68.8% vs 75.0%, 65.8% vs 89.9% vs 68.4%. The combined predicted AUC was 0.873, the sensitivity was 89.6%, and the specificity was 82.3%. The Kaplan-Meier survival curve showed that the 28-day mortality rates of sepsis patients with APACHE II≥ 18.5, SOFA≥ 11.5 and RDW≥ 13.8 were 58.5%, 80.5% and 59.0%, respectively. In the death group, APACHE II was positively correlated with SOFA, IL-2, and IL-10, and RDW was positively correlated with PLT, TNF-α, CD3 + lymphocyte count, and CD8 + lymphocyte count. Conclusion: Sepsis patients with high APACHE II, SOFA and RDW levels at admission have an increased 28-day mortality rate. The elevation of these indicators in dead patients are related to immune dysfunction. Keywords: sepsis, APACHE II, SOFA, red blood cell distribution width, mortality, immune dysfunction Sepsis is a syndrome of physiological, pathological and biochemical abnormalities caused by infection 1 and is a significant public health problem. The consensus on sepsis in 1991 declared that sepsis was caused by systemic inflammatory response syndrome (SIRS) of the host against infection. 2 Sepsis complicated with organ dysfunction is known as the severe type, which can progress to septic shock. 3 With the lack of further understanding of sepsis, its definition was gradually revised and improved. In 2016, sepsis was redefined as life-threatening organ dysfunction caused by the uncontrolled inflammatory response of the body. Judging by the acute increase of the SOFA score > 2 points, as described in Sepsis 3.0. 4 Sepsis patients have a high mortality rate. More than 250,000 sepsis patients die yearly in the United States, and the inpatient mortality rate is about 26%. 5 However, timely targeted interventions can improve the outcome of sepsis patients. 6 Therefore, identifying sepsis patients with a high risk of death in the early stage has significant clinical value. Research has shown that sepsis can be divided into an initial immune activation stage and a chronic immune suppression stage, ultimately leading to immune cell death. Due to the lack of specific treatment methods for sepsis, sustained damage to the host's immune system can lead to an increase in sepsis-related mortality. 7 In addition, studies have found that during sepsis, the inhibitor proteins of the immune checkpoint were usually up-regulated and could be used as potential targets for diagnosing and treating sepsis and helped reduce sepsis mortality. 8 However, our knowledge of immune physiology related to -Abstract Truncated-
pharmacology & pharmacy,infectious diseases